Skip to main content
  • Imaging
      |Imaging
    • Cardiac
    • Clinical Research
    • COVID
    • Interventional
    • Molecular
    • Neuro
    • Nuclear
    • Oncology
    • Orthopedic
    • Radiation Oncology
    • Screening
    • Women's
  • Technology
      |Technology
    • Artificial Intelligence
    • Contrast
    • CT
    • Enterprise Imaging
    • Imaging Informatics
    • Informatics
    • MRI
    • PACS
    • PET/CT
    • Ultrasound
    • X-Ray
  • Management
      |Management
    • Education & Training
    • Leadership
    • Patient Care
    • Policy & Regulations
    • Practice Management
    • Professional Associations
    • Quality
    • Staffing
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHRA
    • ACR
    • ARRS
    • ASRT
    • RBMA
    • RSNA
    • SBI
    • SCCT
    • SIIM
    • SIR
    • SNMMI
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe

Search form

Home

AI-enabled devices lacking validation data prior to FDA clearance more likely to be recalled

warning safety alert recall healthcare issue

FDA 510(k) clearance does not require that AI devices are subject to prospective human studies prior to approval.

  • Read more about AI-enabled devices lacking validation data prior to FDA clearance more likely to be recalled

Woman dies following severe allergic reaction to CT contrast

The 22-year-old patient was undergoing a computed tomography exam with contrast due to her history of kidney stones.

  • Read more about Woman dies following severe allergic reaction to CT contrast

Fluorescent contrast agent noninvasively identifies common skin cancer

Fluorescent contrast agent helps diagnose basal cell carcinoma.

PARPi-FL-labeled (10 μM) FCM signal at 5 minutes in excised human BCC lesions through intact skin.

When used topically, the agent penetrates the skin and generates a fluorescent signal under the guidance of a fluorescent confocal microscope.

  • Read more about Fluorescent contrast agent noninvasively identifies common skin cancer

Hospital apologizes after imaging delay results in needle being left in patient

artificial intelligence AI in healthcare

Photo by Jonathan Borba via Pexels 

The organization is under fire after the patient’s wife charged that it could have prevented her husband’s untimely death. 

  • Read more about Hospital apologizes after imaging delay results in needle being left in patient

Pivoting to a pay per study model—join our webinar Tuesday

radiologist radiology pay compensation money dollar

Join three imaging experts on Aug. 26 to learn more about imaging storage-as-a-service in which you pay once to save and manage a study forever, with costs as low as 2.5 cents per exam.

  • Read more about Pivoting to a pay per study model—join our webinar Tuesday

Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

Dual-mode radiotracer helps surgeons 'hear' invisible cancer lesions

When used during surgery, it can help providers identify cancerous lesions that are not in their immediate vision. 

  • Read more about Surgeons can 'hear' cancerous lesions with help of new dual-mode radiotracer

New MRI findings may explain why some amputees struggle with phantom pain

prosthetic.jpg
Photo by ThisIsEngineering via Pexels

New research refutes the notion that parts of the brain controlling specific extremities remap themselves following amputation, which would prevent patients from feeling pain associated with the removed appendage. 

  • Read more about New MRI findings may explain why some amputees struggle with phantom pain

FDA clears CCTA AI coronary plaque assessment from Artrya

Australia-based Artrya Limited said its Salix Coronary Plaque module AI-powered cloud platform offers near-real time, point-of-care CCTA assessment and management of coronary artery disease.

Australia-based Artrya Limited says its AI-enabled Salix Coronary Plaque module offers near real-time, point-of-care CCTA assessment and management of coronary artery disease. 

  • Read more about FDA clears CCTA AI coronary plaque assessment from Artrya

New hypertension management recs support use of interventional radiology procedure

The U.S. Food and Drug Administration (FDA) has approved Recor Medical’s Paradise Ultrasound Renal Denervation (RDN) system for uncontrolled hypertension. The Recor system gained FDA clearance in November 2023.

Paradise Ultrasound image courtesy of Recor Medical. 

In patients with treatment-resistant hypertension, the procedure has the potential to produce sustained blood pressure reductions for 36 months or longer. 

  • Read more about New hypertension management recs support use of interventional radiology procedure

Ultrasound use during IUD removals is on the rise

interventional ultrasound

Removals are routinely completed in outpatient offices, but occasionally when complications make them more challenging, providers turn to additional tools for assistance. 

  • Read more about Ultrasound use during IUD removals is on the rise

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …4
    • Page 5
    • Page 6
    • Page 7
    • Current page 8
    • Page 9
    • Page 10
    • Page 11
    • Page 12 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme